Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Belatacept Removal by Plasmapheresis: Dose Adjustments and Clinical Recommendations.
Wilson NK, Tremblay S, Shields AR, Woodle ES, Alloway RR, Vinks AA, Miyagawa B, Mizuno T. Wilson NK, et al. Among authors: shields ar. Transplant Direct. 2024 Jul 5;10(8):e1677. doi: 10.1097/TXD.0000000000001677. eCollection 2024 Aug. Transplant Direct. 2024. PMID: 38988686 Free PMC article. No abstract available.
Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality.
Shi T, Burg AR, Caldwell JT, Roskin KM, Castro-Rojas CM, Chukwuma PC, Gray GI, Foote SG, Alonso JA, Cuda CM, Allman DA, Rush JS, Regnier CH, Wieczorek G, Alloway RR, Shields AR, Baker BM, Woodle ES, Hildeman DA. Shi T, et al. Among authors: shields ar. J Clin Invest. 2023 Jul 17;133(14):e170191. doi: 10.1172/JCI170191. J Clin Invest. 2023. PMID: 37227784 Free PMC article.
Single cell transcriptomic analysis of renal allograft rejection reveals novel insights into intragraft TCR clonality.
Shi T, Burg AR, Caldwell JT, Roskin K, Castro-Rojas CM, Chukwuma PC, Gray GI, Foote SG, Alonso J, Cuda CM, Allman DA, Rush JS, Regnier CH, Wieczorek G, Alloway RR, Shields AR, Baker BM, Woodle ES, Hildeman DA. Shi T, et al. Among authors: shields ar. bioRxiv [Preprint]. 2023 Feb 13:2023.02.08.524808. doi: 10.1101/2023.02.08.524808. bioRxiv. 2023. Update in: J Clin Invest. 2023 Jul 17;133(14):e170191. doi: 10.1172/JCI170191 PMID: 36798151 Free PMC article. Updated. Preprint.
Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance: Two-Year Results of a Prospective, Randomized Multicenter Trial.
Kaufman DB, Woodle ES, Shields AR, Leone J, Matas A, Wiseman A, West-Thielke P, Sa T, King EC, Alloway RR; BEST Study Group. Kaufman DB, et al. Among authors: shields ar. Clin J Am Soc Nephrol. 2021 Sep;16(9):1387-1397. doi: 10.2215/CJN.13100820. Epub 2021 Jul 7. Clin J Am Soc Nephrol. 2021. PMID: 34233921 Free PMC article. Clinical Trial.
Reducing Donor-specific Antibody During Acute Rejection Diminishes Long-term Renal Allograft Loss: Comparison of Early and Late Rejection.
Lichvar AB, Tremblay S, Leino AD, Shields AR, Cardi MA, Abu Jawdeh BG, Govil A, Kremer J, Cuffy M, Paterno F, Diwan T, Brailey P, Girnita A, Alloway RR, Woodle ES. Lichvar AB, et al. Among authors: shields ar. Transplantation. 2020 Nov;104(11):2403-2414. doi: 10.1097/TP.0000000000003145. Transplantation. 2020. PMID: 32000256
Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trial.
Woodle ES, Kaufman DB, Shields AR, Leone J, Matas A, Wiseman A, West-Thielke P, Sa T, King EC, Alloway RR; BEST Study Group. Woodle ES, et al. Among authors: shields ar. Am J Transplant. 2020 Apr;20(4):1039-1055. doi: 10.1111/ajt.15688. Epub 2020 Feb 6. Am J Transplant. 2020. PMID: 31680394 Free article. Clinical Trial.
34 results